#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Esteve acquires German pharmaceutical company Riemser

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | January 8, 2020
Esteve announced that they have come to an agreement to acquire all the shares of the German pharmaceutical company Riemser from Ardian.
Acquisition   Esteve
Headquartered in Berlin, Riemser has a portfolio of products with the 3 main therapeutic areas being: oncology, neurology and niche therapies.

Topics: Esteve acquire German pharmaceutical Riemser

Riemser operates a pharmaceutical manufacturing plant in Germany and has direct geographical presence in four of Europe's five major countries: Germany, United Kingdom, France, and Spain.

Over 80% of sales come from the hospital channel, providing specialty treatments and a wide range of pharmaceuticals in therapeutic niche areas. ESTEVE's purchase of Riemser will accelerate its transformation into a specialty pharma company with more than 60% of its sales coming from proprietary products; it will also give ESTEVE access to a high-growth sector- the hospital market.